advertisement
Sarkisian SR 27
Showing records 1 to 25 | Display all abstracts from Sarkisian SR117597 36-Month Outcomes from the Prospective GEMINI Study: Canaloplasty and Trabeculotomy Combined with Cataract Surgery for Patients with Primary Open-Angle Glaucoma
Greenwood MD
Clinical Ophthalmology 2023; 17: 3817-3824
117499 Real-World Analysis of the Efficacy of Bimatoprost Sustained-Release Glaucoma Implant Where American Indians Comprise the Largest Minority Population
Sarkisian SR
Clinical Ophthalmology 2024; 18: 917-927
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Sarkisian SR
Ophthalmology 2024; 131: 1021-1032
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Berdahl JP
Drugs 2024; 84: 83-97
117597 36-Month Outcomes from the Prospective GEMINI Study: Canaloplasty and Trabeculotomy Combined with Cataract Surgery for Patients with Primary Open-Angle Glaucoma
Yadgarov A
Clinical Ophthalmology 2023; 17: 3817-3824
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Sarkisian SR
Drugs 2024; 84: 83-97
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Ang RE
Ophthalmology 2024; 131: 1021-1032
117499 Real-World Analysis of the Efficacy of Bimatoprost Sustained-Release Glaucoma Implant Where American Indians Comprise the Largest Minority Population
Mitchell EC
Clinical Ophthalmology 2024; 18: 917-927
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Lee AM
Ophthalmology 2024; 131: 1021-1032
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Ang RE
Drugs 2024; 84: 83-97
117597 36-Month Outcomes from the Prospective GEMINI Study: Canaloplasty and Trabeculotomy Combined with Cataract Surgery for Patients with Primary Open-Angle Glaucoma
Flowers BE
Clinical Ophthalmology 2023; 17: 3817-3824
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Berdahl JP
Ophthalmology 2024; 131: 1021-1032
117597 36-Month Outcomes from the Prospective GEMINI Study: Canaloplasty and Trabeculotomy Combined with Cataract Surgery for Patients with Primary Open-Angle Glaucoma
Sarkisian SR
Clinical Ophthalmology 2023; 17: 3817-3824
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Doan LV
Drugs 2024; 84: 83-97
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Heersink SB
Ophthalmology 2024; 131: 1021-1032
117597 36-Month Outcomes from the Prospective GEMINI Study: Canaloplasty and Trabeculotomy Combined with Cataract Surgery for Patients with Primary Open-Angle Glaucoma
Ohene-Nyako A
Clinical Ophthalmology 2023; 17: 3817-3824
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Kothe AC
Drugs 2024; 84: 83-97
117597 36-Month Outcomes from the Prospective GEMINI Study: Canaloplasty and Trabeculotomy Combined with Cataract Surgery for Patients with Primary Open-Angle Glaucoma
Dickerson JE
Clinical Ophthalmology 2023; 17: 3817-3824
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Burden JH
Ophthalmology 2024; 131: 1021-1032
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Usner DW; Katz LJ
Drugs 2024; 84: 83-97
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Doan LV
Ophthalmology 2024; 131: 1021-1032
117597 36-Month Outcomes from the Prospective GEMINI Study: Canaloplasty and Trabeculotomy Combined with Cataract Surgery for Patients with Primary Open-Angle Glaucoma
Clinical Ophthalmology 2023; 17: 3817-3824
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Stephens KG
Ophthalmology 2024; 131: 1021-1032
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Navratil T
Drugs 2024; 84: 83-97
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Kothe AC
Ophthalmology 2024; 131: 1021-1032
